Article
Selection Strategies and Practical Application of BRAF V600E-Mutated Non-Small Cell Lung Carcinoma.
Cancer research and treatment - 1 Jul 2022
Hwang Inwoo, Choi Yoon-La, Lee Hyunwoo, Hwang Soohyun, Lee Boram, Yang Hobin, Chelakkot Chaithanya, Han Joungho
Abstract excerpt
PURPOSE: The incidence of BRAF V600E mutation in non-small cell lung carcinoma (NSCLC) is lower than 2%, which poses difficulties in finding legitimate patients for targeted therapy. We investigated the predictive factors pertaining to BRAF V600E and the effectiveness of the VE1 antibody as a scr...
Topics
- Adenocarcinoma
- Biomarkers, Tumor
- Carcinoma, Non-Small-Cell Lung
- ErbB Receptors
- Female
- Humans
- Lung Neoplasms
- Mutation
- Proto-Oncogene Proteins B-raf
- Receptor Protein-Tyrosine Kinases